CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+7.66%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$373M
AUM Growth
+$373M
Cap. Flow
-$46.3M
Cap. Flow %
-12.42%
Top 10 Hldgs %
44.78%
Holding
63
New
17
Increased
9
Reduced
13
Closed
10

Top Buys

1
QCOR
QUESTCOR PHARMA INC
QCOR
$18.5M
2
CELG
Celgene Corp
CELG
$17.2M
3
AKBA icon
Akebia Therapeutics
AKBA
$11.1M
4
OMER icon
Omeros
OMER
$10.8M
5
HRTX icon
Heron Therapeutics
HRTX
$8.62M

Top Sells

1
MDVN
MEDIVATION, INC.
MDVN
$38.6M
2
CBST
CUBIST PHARMACEUTICALS INC
CBST
$21.9M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$20.5M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$16.5M
5
IDIX
IDENIX PHARMACEUTICALS INC
IDIX
$15.1M

Sector Composition

1 Healthcare 78.92%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARAV
26
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.61M 1.49%
+33,333
New +$5.61M
RARE icon
27
Ultragenyx Pharmaceutical
RARE
$3.04B
$5.39M 1.43%
120,000
+60,000
+100% +$2.69M
AGTC
28
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.05M 1.34%
+218,600
New +$5.05M
ALKS icon
29
Alkermes
ALKS
$4.95B
$5.03M 1.33%
100,000
-100,000
-50% -$5.03M
RMTI icon
30
Rockwell Medical
RMTI
$59.6M
$4.8M 1.27%
36,364
– –
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
$4.56M 1.21%
1,000,000
-750,000
-43% -$3.42M
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
$4.49M 1.19%
300,000
-100,000
-25% -$1.5M
NBIX icon
33
Neurocrine Biosciences
NBIX
$13.5B
$4.45M 1.18%
+300,000
New +$4.45M
CBPO
34
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$4.45M 1.18%
+100,000
New +$4.45M
QTNT
35
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4.18M 1.11%
+12,500
New +$4.18M
SCTL
36
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$4.01M 1.06%
557,500
– –
CBIO
37
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$3.98M 1.05%
4,723
+29
+0.6% +$24.4K
PTCT icon
38
PTC Therapeutics
PTCT
$4.41B
$3.92M 1.04%
150,000
-400,000
-73% -$10.5M
GNVC
39
DELISTED
GenVec, Inc.
GNVC
$3.42M 0.91%
132,930
– –
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$58.6B
$3.16M 0.84%
50,000
– –
ALDR
41
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$3.01M 0.8%
+150,000
New +$3.01M
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
$2.9M 0.77%
70,000
-50,000
-42% -$2.07M
AGEN
43
Agenus
AGEN
$136M
$2.9M 0.77%
45,855
-5,095
-10% -$322K
NGNE icon
44
Neurogene
NGNE
$284M
$2.83M 0.75%
15,000
+2,656
+22% +$501K
DARE icon
45
Dare Bioscience
DARE
$27.4M
$2.61M 0.69%
+3,750
New +$2.61M
ASPX
46
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$2.23M 0.59%
100,000
– –
KIN
47
DELISTED
Kindred Biosciences, Inc.
KIN
$1.86M 0.49%
+100,000
New +$1.86M
RGLS
48
DELISTED
Regulus Therapeutics
RGLS
$1.61M 0.43%
1,667
– –
AGRX
49
DELISTED
Agile Therapeutics, Inc
AGRX
$1.31M 0.35%
+75
New +$1.31M
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.34B
$1.13M 0.3%
50,000
-250,000
-83% -$5.65M
1
2
3